🚀 Targeted DNA & RNA Sequencing Market Set for Explosive Growth (2026–2035)
The global targeted DNA/RNA sequencing market is entering a high-growth phase, driven by precision medicine, oncology breakthroughs, and rapid AI integration in genomics.
The global targeted DNA RNA sequencing market size was evaluated at USD 14.98 Bn in 2025 and is anticipated to reach around USD 84.62 Bn by
Market Snapshot
USD 17.89B in 2026 USD 84.62B by 2035 CAGR: 18.9% (2026–2035)
Why It’s Growing?
• Rising demand for precision oncology & personalized medicine • Expanding applications in drug discovery (43% share in 2025) • Declining NGS sequencing costs • AI-powered genomic data interpretation • Growing adoption in hospitals & clinical labs
Key Insights
• North America led with 43% market share • Asia-Pacific = fastest-growing region • NGS segment dominated in 2025 • RNA-based sequencing gaining strong momentum • Pharma & biotech segment growing at 20.2% CAGR













